 |
 |
|
|
| |
The Graffinity technology is the premier source for discovery of small molecular hit
and lead compounds. Through our fragment based drug discovery
platform we serve our partners in providing novel small molecules for
drug discovery and chemical genomics approaches. |
|
|
Our Mission
• Combine fragment based drug discovery with low affinity fragment screening
• Serve our partners in providing high quality lead structures
• Become a leading provider of chemo-biological information
and New Chemical Entities |
|
|
|
|
|
| |
 |
|
Graffinity Pharmaceuticals GmbH
Im Neuenheimer Feld 518
69120 Heidelberg, Germany
 Phone: +49 (0)6221 651 00
Fax: +49 (0)6221 651 01 11
E-Mail: 
Web: www.graffinity.com |
|
|
|
|
|
|
